Pdl biopharma Contact Number

All Time Past 24 Hours Past Week Past month Post Your Comments?

Listing Results Pdl biopharma Contact Number

Contact Information PDL BioPharma, Inc.

4 hours ago Investor.pdl.com Show details

PDL BioPharma, Inc > Investor Relations > Investor Relations > Contact Information. Contact Information Headquarters PDL BioPharma, Inc. 10585 Double R. Blvd., Suite 100 Reno, Nevada, 89521 Mailing address: 59 Damonte Ranch Parkway, Suite B- …

Category: Contact SupportShow more

PDL Biopharma Crunchbase Company Profile & Funding

3 hours ago Crunchbase.com Show details

775-832-8500Medical. Headquarters Regions Western US. Founded Date 1986. Operating Status Active. Stock Symbol NASDAQ:PDLI. Company Type For Profit. Number of Exits 6. Phone Number 775-832-8500. PDL BioPharma, Inc. engages in intellectual property asset management, and patent portfolio and related assets investment activities.

Founded: 1986

Category: Contact NumberShow more

Home PDL BioPharma, Inc.

Just Now Pdl.com Show details

PDL Homepage. In July 2020, PDL issued its proxy statement that requested approval by its stockholders of a Plan of Dissolution as the most efficient manner of winding up the Company’s business, paying and making provision to pay its creditors, and distributing the proceeds of its liquidation process to its stockholders pursuant to the Plan of Dissolution.

Category: Home PhoneShow more

Pdl Biopharma, Inc. Company Profile Incline Village, NV

1 hours ago Dnb.com Show details

Find company research, competitor information, contact details & financial data for Pdl Biopharma, Inc. of Incline Village, NV. Get the latest business insights from Dun & Bradstreet.

Employees: 14
Cash and Cash Equivalents: $193.45
Accounts Receivable: $13.55
Location: 932 Southwood Blvd, Incline Village, 89451-7413, NV

Category: Contact NumberShow more

PDL BioPharma engineering Contacts Business Emails, Phone

9 hours ago Adapt.io Show details

Find the PDL BioPharma company's engineering team/department contact details such as business emails, phone numbers, web address and other details. Get …

Category: Phone Number, Contact SupportShow more

Jeff Key PDL BioPharma ZoomInfo.com

6 hours ago Zoominfo.com Show details

View Jeff Key's business profile at PDL BioPharma. Find contact's direct phone number, email address, work history, and more.

Category: Contact NumberShow more

Top Company Profile: Pdl Biopharma Inc, Incline Village NV

1 hours ago Naics.com Show details

15-508-4460Company DUNS#: 15-508-4460: Corporate Name: Pdl Biopharma Inc: Tradestyle Name: Pdl Biopharma: Point of Contact: Restricted: Title: Restricted: Address:

Category: Contact NumberShow more

Pdl Biopharma, Inc. in Raleigh, NC Company Info & Reviews

1 hours ago Bizapedia.com Show details

Pdl Biopharma, Inc. is a North Carolina Foreign Business Corporation filed On February 28, 2007. The company's filing status is listed as Withdrawn and its File Number is 0901178. The Registered Agent on file for this company is Secretary Of State and is located at 2 South Salisbury Street, Raleigh, NC 27601.

Location: NV

Category: Contact NumberShow more

PDL BioPharma Corporate Headquarters, Office Locations and

Just Now Craft.co Show details

All PDL BioPharma Locations. Incline Village (HQ), NV. United States. 932 Southwood Blvd, Incline Village. Report incorrect company information. Location of similar companies. Italfarmaco. Healthcare - Private. Ascentage Pharma.

Category: Contact NumberShow more

PDL BioPharma, Inc.; Rule 14a8 noaction letter

9 hours ago Sec.gov Show details

(202) 637-2332Please contact the undersigned at (202) 637-2332 to discuss any questions you may have regarding this matter. Very truly yours, Brian D. Miller of LATHAM & WATKINS LLP Enclosures cc: Kenneth Steiner John Chevedden Nathan Kryszak, PDL BioPharma, Inc.

Category: Contact NumberShow more

Name of contact for additional information Telephone No

9 hours ago Pdl.com Show details

3 Name of contact for additional information 4 Telephone No. of contact 5 Email address of contact 6 Number and street (or P.O. box if mail is not delivered to street address) of contact 7 City, town, or post office, state, and ZIP code of contact 8 Date of action 9 Classification and description 10 CUSIP number 11 Serial number(s) 12 Ticker

Category: Phone Number, Contact SupportShow more

PDLI Stock Forecast, Price & News (PDL BioPharma)

6 hours ago Marketbeat.com Show details

PDL BioPharma's stock is owned by a number of retail and institutional investors. Top institutional shareholders include Tudor Investment Corp Et Al (0.03%) and BNP Paribas Arbitrage SA (0.03%). Company insiders that own PDL BioPharma stock include Alan Lee Bazaar, Christopher Lewis Stone, David W Gryska, Dominique Monnet, Elizabeth G O'farrell

Category: Contact NumberShow more

Facet biotech Email Addres & Phone Number Lusha

8 hours ago Lusha.com Show details

We are passionate and committed about the work that we do, and we share a common goal of developing therapeutics that will improve people’s lives. Facet Biotech Corporation launched in December 2008 as a spin-off from PDL BioPharma, Inc.

Category: Phone Number, Tech SupportShow more

pdli20141007_8k.htm SEC

5 hours ago Sec.gov Show details

PDL BioPharma, Inc. (Exact name of Company as specified in its charter) 000-19756 (Commission File Number) Delaware : 94-3023969 (State or Other Jurisdiction of Incorporation) (I.R.S. Employer Identification No.) 932 …

Category: Contact NumberShow more

PDL BioPharma Number of Employees 20062020 PDLI

Just Now Macrotrends.net Show details

PDL BioPharma number of employees from 2006 to 2020. Number of employees can be defined as a measure of financial performance calculated as operating cash flow minus capital expenditures, expressed on a per share basis. Protein Design Labs Inc. is a biopharmaceutical company focused on the research, development and commercialization of novel

Category: Contact NumberShow more

PDL Biopharma, Inc. Sample Contracts Law Insider

9 hours ago Lawinsider.com Show details

PDL Biopharma, Inc. – TRANSITION SERVICES AGREEMENT. THIS TRANSITION SERVICES AGREEMENT (this “Agreement”) is made and entered into as of September 30, 2020, by and between PDL BioPharma, Inc., a Delaware corporation (“PDL”) and LENSAR, Inc., a Delaware corporation (“LENSAR”). PDL and LENSAR are referred to herein individually as

Category: Contact NumberShow more

PDL BioPharma Selling off Noden Edison

4 hours ago Edisongroup.com Show details

PDL BioPharma recently announced an agreement to divest its Noden subsidiary to Stanley Capital for up to $48.25m in cash. $12m is due at deal closure (currently expected in mid-August), with an additional $33m to be paid in quarterly instalments from 2021–23. There could potentially be two contingent payments of $3.25m in total. PDL has also announced that …

Category: Contact NumberShow more

PDL BIOPHARMA, INC. (Form: 8K, Received: 09/10/2020 08:33:00)

8 hours ago Content.edgar-online.com Show details

104-20-0001On September 10, 2020, PDL BioPharma, Inc. (“PDL”) issued a press release announcing that PDL’s Board of Directors has approved the separation of LENSAR, Inc. (“LENSAR”), a majority-owned subsidiary of PDL, from PDL in the form of a taxable dividend involving the distribution on October 1, 2020 of all outstanding shares of LENSAR common …

Category: Contact NumberShow more

Pdl Biopharma, Inc. Portfolio Holdings, AUM (13F, 13G)

3 hours ago Fintel.io Show details

020-10-16PDL BioPharma Enters Oversold Territory. 2020-10-16 zacks.com - PDL BioPharma, Inc. (PDLI - Free Report) has been on a bit of a cold streak lately, but there might be light at the end of the tunnel for this overlooked stock. And for technical investors there is some hope when looking at PDLI given that, according to its RSI reading of 28.93, it

Category: Contact NumberShow more

PDL BioPharma Completes Divestiture of the Noden

7 hours ago Prnewswire.com Show details

PDL BioPharma Completes Divestiture of the Noden Pharmaceutical Business to Stanley Capital. INCLINE VILLAGE, Nev., Sept. 9, 2020 /PRNewswire/ -- PDL BioPharma, Inc. ("PDL" or the "Company

Category: Contact NumberShow more

Faheem Hasnain CoFounder & Executive Chairman

8 hours ago Crunchbase.com Show details

Faheem Hasnain is the Chairman of the Board of directors at Ambit Biosciences Corporation. Faheem Hasnain has served as one of our directors since October 2010, and as the chairman of the board since November 2010. Faheem Hasnain is the president and chief executive officer of Receptos, Inc., a drug discovery and development company, a position.

Category: Contact NumberShow more

PDLI Stock Pdl Biopharma, Inc. SEC Filings

Just Now Sec.report Show details

Ticker: PDLI. documents---0.00081515312194824. Pdl Biopharma, Inc. is regulated by the U.S. Security and Exchange Commission and incorporated in the state of Delaware. Pdl Biopharma, Inc is primarely in the business of biological products (no diagnostic substances). For financial reporting, their fiscal year ends on December 31st.

Category: Contact NumberShow more

Pdl Biopharma, Inc. (PDLI) 10K Annual Reports & 10Q SEC

6 hours ago Last10k.com Show details

Entity File Number: 000-19756 : Entity Registrant Name: PDL BioPharma, Inc. Entity Incorporation, State or Country Code: DE : Entity Tax Identification Number: 94-3023969 : Entity Address, Address Line One: 59 Damonte Ranch Parkway : Entity Address, Address Line Two: Suite B-375 : Entity Address, City or Town: Reno : Entity Address, State or

Category: Contact NumberShow more


Just Now Infomemo.theocc.com Show details

NUMBER OF CONTRACTS: No Change MULTIPLIER: 100 (e.g., a premium of 1.50 yields $150; a strike of 3 yields $300) NEW DELIVERABLE PER CONTRACT: 1) 100 PDL BioPharma, Inc. (PDLI) Common Shares 2) 7 (New) LENSAR, Inc. (LNSR) Common Shares 3) Cash in lieu of 0.5879 fractional LNSR Shares SETTLEMENT ALLOCATION: PDLI: 95% …

Category: Contact NumberShow more

PDL Announces Timeline for Voluntarily Delisting from

9 hours ago Markets.businessinsider.com Show details

The Company's Board of Directors considered a number of factors in determining to delist and deregister PDL's common stock, including the costs and expenses associated with being a publicly traded

Category: Contact NumberShow more

PDL BioPharma Dissolution set for the year end Edison

9 hours ago Edisongroup.com Show details

PDL has made significant progress with its stated objective of monetizing and liquidating the company. Most recently, in October, LENSAR was spun off to PDL shareholders and the previously announced sale of Noden was completed in September. Also, the Kybella, Zalviso and Coflex royalties were sold to SWK Holdings for $4.35m and a settlement …

Category: Contact NumberShow more

Hedge Funds Are Selling PDL BioPharma Inc. (PDLI)

9 hours ago Finance.yahoo.com Show details

Contact Us . Contact Us Renaissance Technologies has the number one position in PDL BioPharma Inc. (NASDAQ:PDLI), worth close to $23.2 million, amounting to less than 0.1%% of its total 13F

Category: Contact NumberShow more

Ed Imbrogno Is Always Ready for the Next Challenge Profile

9 hours ago Profilemagazine.com Show details

Ed Imbrogno, PDL BioPharma Photo by Joy Strotz. His career has led him to the position of vice president, chief financial officer, and chief accounting officer for PDL BioPharma, which has managed patents and other investments since 2008. And he expects to start a new chapter sometime fairly soon, as PDL is in the process of monetizing its

Category: Contact NumberShow more

Laurence J. Korn, Former Chief Executive Officer at

2 hours ago Relationshipscience.com Show details

PDL BioPharma, Inc. It operates through the following segments: Income Generating Assets, Pharmaceutical, and Medical Devices. The Income Generating Assets segment consists of revenues derived from notes and other long-term receivables, royalty rights-at fair value, equity investments, and royalties from issued patents in the United States and

Category: Contact NumberShow more

PDL Announces Timeline for Voluntarily Delisting from

3 hours ago Biospace.com Show details

PDL Announces Timeline for Voluntarily Delisting from Nasdaq. Expects to File a Certificate of Dissolution on January 4, 2021. Trading in PDL's Common Stock on Nasdaq to be Suspended Prior to Market Opening on December 31, 2020. INCLINE VILLAGE, Nev., Dec. 8, 2020 /PRNewswire/ -- PDL BioPharma, Inc. ("PDL" or the "Company") (Nasdaq: PDLI) today

Category: Contact NumberShow more

Tandy Theis Receptionist Philips Healthtech LinkedIn

7 hours ago Linkedin.com Show details

• Answered main phone number • Updated contact list PDL BioPharma Jul 1997 - Dec 2007 10 years 6 months. Brooklyn Park, MN

Title: Philips Healthtech
Location: Long Lake, Minnesota, United States
Connections: 197

Category: Tech SupportShow more

Brian Schmidt Senior Director, Analytical Development

6 hours ago Linkedin.com Show details

Brian Schmidt Senior Director, Analytical Development, BioProcess Development, and QC at AbbVie Redwood City, California, United States 387 connections

Title: Senior Director, Analytical …
Location: Redwood City, California, United States
Connections: 387

Category: Contact NumberShow more

PDL Biopharma (PDLI) – Liquidation – 25% Upside Special

3 hours ago Specialsituationinvestments.com Show details

Alphaeon $0.05/share: The company owns 1.7 mil shares of Alphaeon, a private company which PDL valued at $6.6 mil at YE19 or 5 cents per PDL share. Alphaeon itself has a number of assets including 8.7 mil shares of Evolus which they are distributing …

Category: Contact NumberShow more

Mark McDade Qiming Venture Partners ChinaBio

Just Now Informaconnect.com Show details

Mark McDade joined Qiming Venture Partners USA in 2017 and is based in Cambridge, MA. Before joining the Qiming team, Mark was Executive Vice President, COO at UCB. He led UCB’s worldwide Geographic Operations, Established Brands, Technical Operations and Business Development. He joined UCB’s Executive Committee in 2008.From 2002 until late 2007, Mark …

Category: Contact NumberShow more

Is PDLI A Good Stock To Buy Now? Yahoo

9 hours ago Finance.yahoo.com Show details

The largest stake in PDL BioPharma Inc. (NASDAQ:PDLI) was held by Park West Asset Management, which reported holding $28.9 million worth of stock at the end of September.It was followed by

Category: Contact NumberShow more

Valeant Pays $13M To End Diabetes Drug Royalty Claims Law360

1 hours ago Law360.com Show details

In 2013, PDL BioPharma paid Depomed $240.5 million for the right to receive royalties from sales of Depomed's Type 2 diabetes drugs, including those owed by Santarus Inc.

Category: Contact NumberShow more

PDL BIOPHARMA, INC. : PDLI Stock Price US69329Y1047

7 hours ago Marketscreener.com Show details

PDL BioPharma, Inc. has a portfolio of income generating assets based on alternative financings. These alternative financings fall into one of three categories: royalty monetization, debt structures and hybrids of the two. The Company's investments are typically in assets with strong intellectual property protection and are commercial stage or

Category: Contact NumberShow more

PDL Announces Timeline for Voluntarily Delisting from Nasdaq

8 hours ago Nasdaq.com Show details

020-12-08--PDL BioPharma, Inc. today announced that it has formally notified The Nasdaq Stock Market, Inc. of its intent to delist the Company's common stock from the Nasdaq Global Select Market. PDL

Category: Contact NumberShow more

LENSAR, INC. :: Delaware (US) :: OpenCorporates

Just Now Opencorporates.com Show details

Company Number 3843263 Incorporation Date 20 August 2004 (about 17 years ago) Company Type Corporation Jurisdiction Delaware (US) Controlling Company PDL BIOPHARMA, INC. Agent Name NATIONAL REGISTERED AGENTS, INC Agent Address 160 GREENTREE DR STE 101, DOVER, Kent, DE, 19904 Directors / Officers. NATIONAL …

Category: Contact NumberShow more

Noden Pharma DAC

8 hours ago Nodenpharma.com Show details

908-758-1210Noden Pharma USA Inc. 233 Mt. Airy Rd Suite 164 Basking Ridge, NJ 07920, USA Phone: 908-758-1210 Email: [email protected]

Category: Contact NumberShow more

PDLI Insider Trading PDL BIOPHARMA Inc Form 4 SEC Filings

1 hours ago Secform4.com Show details

Insider Trading - PDL BIOPHARMA Inc Select Time period: 1 Month 2 Months 3 Months 6 Months 1 Year 2 Years 3 Years 4 Years 5 Years 6 Years 7 Years 8 Years 9 Years 10 Years 11 Years 12 Years 13 Years 14 Years 15 Years 16 Years 17 …

Category: Contact NumberShow more

RepTech Systems

6 hours ago Reptechsystems.com Show details

480-828-0993Fill out the form, register as a vendor, and accept the terms and conditions. For inquiries, don't hesitate to contact us at 480-828-0993.

Category: Tech SupportShow more

Judge Voids PDL Antibody Patent In MedImmune Suit Law360

8 hours ago Law360.com Show details

PDL Biopharma Inc., case number 5:08-cv-05590, in the U.S. District Court for the Northern District of California. For a reprint of this article, please contact [email protected]law360.com . Attached

Category: Contact NumberShow more

Corporate Governance :: Molecular Templates, Inc. (MTEM)

1 hours ago Mtem.com Show details

Nominating and Corporate Governance. Harold E. “Barry” Selick, Ph.D. has served as a member of Molecular Templates’ Board of Directors since August 2017. He is currently the Vice-Chancellor of Business Development, Innovation, and Partnerships at the University of California, San Francisco, a position that he has held since April 2017.

Category: Contact NumberShow more

PDL BioPharma Valuation Today PDLI Macroaxis

4 hours ago Macroaxis.com Show details

PDL BioPharma seems to be undervalued based on Macroaxis valuation methodology. Our model determines the value of PDL BioPharma from evaluating the company fundamentals such as current valuation of 213.07 M, and Return On Equity of (7.36) % as well as inspecting its technical indicators and Probability Of Bankruptcy.In general, we support locking in …

Category: Contact NumberShow more

Whisper Number Impact: Earnings Preview For PDL BioPharma

7 hours ago Seekingalpha.com Show details

PDL BioPharma (NASDAQ:PDLI) is expected to report earnings after the close on Thursday, May 9. The whisper number is $0.43, eight cents ahead of analysts' estimate.

Category: Contact NumberShow more

All Time Past 24 Hours Past Week Past month

Please leave your comments here:

Brand New Updated

Frequently Asked Questions

Where is PDL BioPharma located?

PDL BioPharma is headquartered at 932 SOUTHWOOD BLVD, INCLINE VILLAGE NV, 89451. How can I contact PDL BioPharma?

Why invest in pdpdl Biopharma?

PDL BioPharma seeks to provide a significant return for its shareholders by acquiring commercial stage pharmaceutical assets with multiple year revenue growth potential as well as late clinical stage pharmaceutical products.

What happened to PDL stock?

As announced on December 8, 2020, the voluntary suspension of trading and subsequent delisting of PDL’s common stock (Nasdaq: PDLI) occurred prior to market opening on December 31, 2020. The Company’s transfer books closed as of the filing of the certificate of dissolution on January 4, 2021 (the “Final Record Date”).

When is PDL BioPharma's (PDL) next earnings date?

View MarketBeat's top stock picks here. When is PDL BioPharma's next earnings date? PDL BioPharma is scheduled to release its next quarterly earnings announcement on Thursday, September 23rd 2021. View our earnings forecast for PDL BioPharma.

Popular Brands